- COVID-19 and the Human Gut Microbiome: An Under-Recognized Association
-
Abbasi AF, Marinkovic A, Prakash S, Sanyaolu A, Smith S
- KMID: 2533274
- Chonnam Med J.
- 2022 Sep;58(3):96-101.
- doi: 10.4068/cmj.2022.58.3.96
Coronavirus disease 2019 (COVID-19) is an infectious disease with a wide range of respiratory and extrapulmonary symptoms, as well as gastrointestinal symptoms. Despite recent research linking gut microbiota to infectious diseases... -
- CITED
-
- Close
- SHARE
-
- Close
- Candida auris: An Overview of the Emerging Drug-Resistant Fungal Infection
-
Sanyaolu A, Okorie C, Marinkovic A, Abbasi AF, Prakash S, Mangat J, Hosein Z, Haider N, Chan J
- KMID: 2531013
- Infect Chemother.
- 2022 Jun;54(2):236-246.
- doi: 10.3947/ic.2022.0008
Candida auris is an invasive fungal pathogen that has been recognized globally as a serious health threat due to its extensive innate and acquired resistance to antifungal drugs. A growing... -
- CITED
-
- Close
- SHARE
-
- Close
- Reactogenicity to COVID-19 vaccination in the United States of America
-
Sanyaolu A, Marinkovic A, Prakash S, Desai P, Haider N, Abbasi AF, Mehraban N, Jain I, Ekeh A, Shazley O, Okorie C, Orish VN
- KMID: 2534933
- Clin Exp Vaccine Res.
- 2022 Jan;11(1):104-115.
- doi: 10.7774/cevr.2022.11.1.104
Purpose In the United States, Pfizer-BioNTech, Moderna, and Janssen’s coronavirus disease 2019 (COVID-19) vaccines have been granted Emergency Use Authorization (EUA) with the Pfizer-BioNTech vaccine presently approved by the US Food... -
- CITED
-
- Close
- SHARE
-
- Close
